Why the Infratil (ASX:IFT) share price is trading higher today

The Infratil Ltd (ASX: IFT) share price is trading up today. We take a look at the latest announcement to find out why.

The Infratil Ltd (ASX: IFT) share price is lifting this morning after the company released an update on the valuation of its investment in Canberra Data Centres (CDC).

At the time of writing, the Infratil share price is trading up 1.8% at $7.04.

A happy businessman pointing up, inidicating a rise in share price

Image source: Getty Images

Increase in demand driving value

After the independent valuation, Infratil's 48.1% investment in CDC is now valued at between $2,039 million to $2,334 million, as at the end of December 2020. This is a substantial increase from the previous valuation in September, ranging between $1,597 million to $1,807 million.

The nearly 28% uplift in value, from the bottom end of valuer estimates, is reportedly a result of accelerated demand in both new and existing customers for its data centre services. This surprise uptake has the company expecting existing data centres to reach capacity sooner than first thought.

Infratil said it would provide further details of CDC's growth plans at the company's investor day on 16 February.

The price for performance

The New Zealand-based infrastructure investment company implements an incentive model. The fee payable by Infratil acts as a monetary reward to the entities for delivering growth in the value of the investment.

The revised value of its CDC investment is expected to increase the international portfolio annual incentive fee (IPAIF) to $147.6 million. This is up from $57.7 million since the provided September estimate.

Infratil noted that it has not assessed incentive fees since September in regards to other investments.  These investments include Tilt Renewables Ltd (ASX: TLT), Longroad Energy, Retire Australia, and Australian Social Infrastructure Partners.

The final IPAIF will be payable to investments on 31 March 2021.

What's next?

The Infratil share price has performed solidly over the last year, returning 39.9% in the last 12 months. This compares to the S&P/ASX 200 Index (ASX: XJO) which fell 2.17%.

The company performance has not gone unrecognised either – with AustralianSuper lobbying a takeover bid back in early December. This offer was rejected by the board, as they believed it undervalued the high quality and unique portfolio of assets.

Infratil expects it will conclude its strategic review of its investment of Tilt Renewables within the next 6 months. The company conveyed the potential of divestment of the renewable energy provider back in December.

Motley Fool contributor Mitchell Lawler has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on ASX Share Market News

A woman weraing a stripy t-shirt winks as she points to the decorative gold crown on her head.
ASX Share Market News

CBA shares back on top of the ASX 200 as BHP dives 13% this week

CBA shares have rallied 9.5% over the past month whilst BHP tumbled 13% this week.

Read more »

a man wearing a hard hat and a high visibility vest stands with his arms crossed in front of heavy equipment at a mine site.
Broker Notes

BHP share price drops 13% to seven-month low in just 1 week. Do experts say buy?

Market analysts offer their advice as BHP shares plunge this week.

Read more »

A distressed young woman reads bad news on her smartphone while standing in a modern indoor setting.
Broker Notes

5 ASX 200 shares experts recommend we buy amid the market carnage this week

ASX 200 shares are down 5.2% this week and back in the red for 2026 overall.

Read more »

Comical investor reading documents and surrounded by calculators.
Broker Notes

Buy, hold, sell: Hub24, Reece, Ramsay Healthcare shares

Analysts reveal their ratings on this financial services provider, plumbing supplies company, and private hospital operator.

Read more »

IPO spelt out on a laptop with a red and green bar chart underneath.
IPOs

Anthropic hits the market. Was it enough to distract investors from a bruised AI sector and Nvidia's scandal?

Was the biggest IPO in US history enough to re-energise the AI trade?

Read more »

A man with his back to the camera holds his hands to his head as he looks to a jagged red line trending sharply downward.
Broker Notes

Three of the worst performers in the ASX 200. Brokers think they're ready to bounce back

There could be a lot of value in these poor performers.

Read more »

Business man marking buy on board and underlining it.
Broker Notes

Leading brokers name 3 ASX shares to buy today

Brokers believe that now could be the time to buy these shares.

Read more »

Medical workers examine an x-ray or scan in a hospital laboratory.
Broker Notes

2 ASX shares tipped to grow up to 122% in the next 12 months

These companies could be on the cusp of something big.

Read more »